Intermolecular Stock Fundamentals
Intermolecular fundamentals help investors to digest information that contributes to Intermolecular's financial success or failures. It also enables traders to predict the movement of Intermolecular Stock. The fundamental analysis module provides a way to measure Intermolecular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intermolecular stock.
Intermolecular |
Intermolecular Company Profit Margin Analysis
Intermolecular's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Intermolecular Profit Margin | 12.89 % |
Most of Intermolecular's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intermolecular is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Intermolecular has a Profit Margin of 12.89%. This is 1091.54% lower than that of the Technology sector and 201.26% lower than that of the Semiconductor Equipment & Materials industry. The profit margin for all United States stocks is notably lower than that of the firm.
Intermolecular Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intermolecular's current stock value. Our valuation model uses many indicators to compare Intermolecular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intermolecular competition to find correlations between indicators driving Intermolecular's intrinsic value. More Info.Intermolecular is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies reporting about 0.36 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Intermolecular is roughly 2.78 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intermolecular by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intermolecular's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intermolecular's earnings, one of the primary drivers of an investment's value.Intermolecular Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intermolecular's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intermolecular could also be used in its relative valuation, which is a method of valuing Intermolecular by comparing valuation metrics of similar companies.Intermolecular is currently under evaluation in profit margin category among related companies.
Intermolecular Fundamentals
Return On Equity | 35.45 | |||
Return On Asset | 12.76 | |||
Profit Margin | 12.89 % | |||
Operating Margin | (45.02) % | |||
Current Valuation | 49.2 M | |||
Shares Outstanding | 49.76 M | |||
Shares Owned By Insiders | 30.13 % | |||
Shares Owned By Institutions | 0.37 % | |||
Number Of Shares Shorted | 4.43 K | |||
Price To Earning | (3.08) X | |||
Price To Book | 2.15 X | |||
Price To Sales | 2.35 X | |||
Revenue | 25.45 M | |||
Gross Profit | 23.65 M | |||
EBITDA | (8.31 M) | |||
Net Income | (10.88 M) | |||
Cash And Equivalents | 23.91 M | |||
Cash Per Share | 0.48 X | |||
Total Debt | 13.65 M | |||
Debt To Equity | 49.10 % | |||
Current Ratio | 4.74 X | |||
Book Value Per Share | 0.85 X | |||
Cash Flow From Operations | (6.01 M) | |||
Short Ratio | 0.03 X | |||
Earnings Per Share | (0.22) X | |||
Number Of Employees | 88 | |||
Beta | 0.57 | |||
Market Capitalization | 59.71 M | |||
Total Asset | 69.68 M | |||
Retained Earnings | (176.41 M) | |||
Working Capital | 32.81 M | |||
Current Asset | 43.05 M | |||
Current Liabilities | 10.24 M | |||
Z Score | 1.0 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intermolecular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intermolecular's short interest history, or implied volatility extrapolated from Intermolecular options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Intermolecular Stock
If you are still planning to invest in Intermolecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intermolecular's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data |